Lactobacilli at the front line of defense against vaginally acquired infections

Future Microbiology

Volumn 6, Issue 5, 2011, Pages 567-582

  Spurbeck, Rachel R ^a,b   Arvidson, Cindy Grove ^a,c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Michigan State University ^*  (United States)

Author keywords

Lactobacillus; mechanism of inhibition; probiotics; vaginally acquired infection

Indexed keywords

BACTERIOCIN; BIOSURFACTANT; LACTOBACILLUS CASEI EXTRACT; MUCIN; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; CHLAMYDIA; FEMALE; GENE EXPRESSION; GONORRHEA; HOST CELL; HUMAN; LACTOBACILLUS; MICROFLORA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION; UROGENITAL SYSTEM; VAGINA; VAGINITIS;

ANIMALS; BACTERIA; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; LACTOBACILLUS; MICE; PROBIOTICS; VAGINA;

ANIMALIA; LACTOBACILLUS;

EID: 79956118059     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.36     Document Type: Review

References (173)

1. Papaioannou S, Bourdrez P, Varma R, Afnan M, Mol BW, Coomarasamy A: Tubal evaluation in the investigation of subfertility: A structured comparison of tests. BJOG 111(12), 1313-1321 (2004). (Pubitemid 39665019)
2. Westrom LV: Chlamydia and its effect on reproduction. J. Br. Fer. Soc. 1(1), 23-30 (1996). (Pubitemid 26186918)
3. Westrom L, Eschenbach D: Pelvic Inflammatory Disease. In:Sexually Transmitted Diseases (3rd Edition). Holmes KK, Sparling PF, Mardh P et al. (Eds). McGraw-Hill, NY, USA 789-809 (1999).
4. Røttingen J-A, Cameron W, Garnett GP: A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: How much really is known? Sex. Transm. Dis. 28(10), 579-597 (2001). (Pubitemid 32937567)
5. Johnson LF, Lewis DA: The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and meta-analysis. Sex. Transm. Dis. 35(11), 946-959 (2008).
6. Laga M, Manoka A, Kivuvu M et al.: Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 7(1), 95-102 (1993). (Pubitemid 23069039)
7. Guenthner PC, Secor WE, Dezzutti CS: Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: Implications for the sexual transmission of HIV-1. Infect. Immun. 73(7), 4155-4160 (2005). (Pubitemid 40923157)
8. Eschenbach D: Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clin. Infect. Dis. 16(4), S282-S287 (1993). (Pubitemid 23157928)
9. Dumonceaux TJ, Schellenberg J, Goleski V et al.: Multiplex detection of bacteria associated with normal microbiota and with bacterial vaginosis in vaginal swabs by use of oligonucleotide-coupled fluorescent microspheres. J. Clin. Microbiol. 47(12), 4067-4077 (2009).
10. Menard P-P, Fenollar F, Henry M, Bretelle F, Raoult D: Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin. Infect. Dis. 47(1), 33-43 (2008). (Pubitemid 351920584)
11. Pybus V, Onderdonk AB: Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect. 1(4), 285-292 (1999).
12. Verhelst R, Verstraelen H, Claeys G et al.: Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol. 4, 16 (2004).
13. Ferris MJ, Norori J, Zozaya-Hinchliffe M, Martin DH: Cultivation- independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J. Clin. Microbiol. 45(3), 1016-1018 (2007). (Pubitemid 46427726)
14. Fredricks DN, Fiedler TL, Thomas KK, Mitchell CM, Marrazzo JM: Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J. Clin. Microbiol. 47(3), 721-726 (2009).
15. Koumans EH, Sternberg M, Bruce C et al.: The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex. Transm. Dis. 34(11), 864-869 (2007). (Pubitemid 350287499)
16. Martin HL, Richardson BA, Nyange PM et al.: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180(6), 1863-1868 (1999).
17. Sweet RL: Gynecologic conditions and bacterial vaginosis: Implications for the non-pregnant patient. Infect. Dis. Obstet. Gynecol. 8(3-4), 184-190 (2000). (Pubitemid 30612898)
18. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet R: Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 36(5), 663-668 (2003). • The number of lactobacilli in the human vaginal tract correlates inversely with susceptibility to Chlamydia and gonorrhea upon exposure. (Pubitemid 36259574)
19. Blondeau JM: Current issues in the management of urinary tract infections: Extended-release ciprofloxacin as a novel treatment option. Drugs 64(6), 611-628 (2004). (Pubitemid 38482441)
20. Hooton TM: Recurrent urinary tract infection in women. Int. J. Antimicrob. Agents 17(4), 259-268 (2001). (Pubitemid 32288741)
21. Foxman B: Recurring urinary tract infection: Incidence and risk factors. Am. J. Public Health. 80(3), 331-333 (1990). (Pubitemid 20080925)
22. Ikäheimo R, Siitonen A, Heiskanen T et al.: Recurrence of urinary tract infection in a primary care setting: Analysis of a 1-year follow-up of 179 women. Clin. Infect. Dis. 22(1), 91-99 (1996). (Pubitemid 26022018)
23. Musser JM, Schlievert PM, Chow AW et al.: A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl Acad. Sci. USA 87(1), 225-229 (1990).
24. Shands KN, Schmid GP, Dan BB et al.: Toxic-shock syndrome in menstruating women: Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303(25), 1436-1442 (1980).
25. Parsonnet J, Hansmann MA, Delaney ML et al.: Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol. 43(9), 4628-4634 (2005). (Pubitemid 41298254)
26. Nannini E, Murray BE, Arias CA: Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr. Opin. Pharm. 10(5), 516-521 (2010).
27. Thomas CM, Hothersall J, Willis CL, Simpson TJ: Resistance to and synthesis of the antibiotic mupirocin. Nat. Rev. Microbiol. 8(4), 281-289 (2010).
28. Hansen SM, Uldbjerg N, Kilian M, Sorensen UBS: Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J. Clin. Microbiol. 42(1), 83-89 (2004). (Pubitemid 38082703)
29. Puopolo KM, Madoff LC, Eichenwald EC: Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115(5), 1240-1246 (2005). (Pubitemid 43843226)
30. Zhou X, Brown CJ, Abdo Z et al.: Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 1(2), 121-133 (2007). • By deep sequencing, the vaginal microbiota in healthy women can be categorized into eight microbial communities, five of which are dominated by lactobacilli. (Pubitemid 46878155)
31. Hyman RW, Fukushima M, Diamond L, Kumm J, Giudice LC, Davis RW: Microbes on the human vaginal epithelium. Proc. Natl Acad. Sci. USA 102(22), 7952-7957 (2005). (Pubitemid 40781044)
32. Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ: Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150(8), 2565-2573 (2004). (Pubitemid 39173262)
33. Burton JP, Cadieux PA, Reid G: Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl. Env. Microbiol. 69(1), 97-101 (2003). (Pubitemid 36077462)
34. Ravel J, Gajer P, Abdo Z et al.: Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4680-4687 (2011). • Five vaginal microbial communities were found by pyrosequencing and the prevalence of these communities differs significantly by ethnic group.
35. Antonio MAD, Hawes SE, Hillier SL: The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 180(6), 1950-1956 (1999).
36. Eschenbach DA, Davick PR, Williams BL et al.: Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27(2), 251-256 (1989). (Pubitemid 19041152)
37. Giorgi A, Torriani F, Dellaglio F, Bo G, Stola E, Bernuzzi L: Identification of vaginal lactobacilli from asymptomatic women. Microbiologica 10(4), 377-384 (1987).
38. Torok MR, Miller WC, Hobbs MM et al.: The association between Trichomonas vaginalis infection and level of vaginal lactobacilli, in nonpregnant women. J. Infect. Dis. 196(7), 1102-1107 (2007). (Pubitemid 47580307)
39. Hawes SE, Hillier SL, Benedetti J et al.: Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 174(5), 1058-1063 (1996). (Pubitemid 26357470)
40. Baeten JM, Hassan WM, Chohan V et al.: Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women. Sex. Transm. Infect. 85(5), 348-353 (2009).
41. Andreu A, Stapleton AE, Fennell CL, Hillier SL, Stamm WE: Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. J. Infect. Dis. 171(15), 1237-1243 (1995).
42. Spurbeck RR, Arvidson CG: Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species. Infect. Immun. 76(7), 3124-3130 (2008). • Lactobacillus jensenii and Lactobacillus gasseri can inhibit the adherence to and invasion of epithelial cells by Neisseria gonorrhoeae.
43. Swidsinski A, Mendling W, Loening-Baucke V et al.: Adherent biofilms in bacterial vaginosis. Obstet. Gynecol. 106(5), 1013-1023 (2005). (Pubitemid 41532908)
44. Boris S, Suarez JE, Vazquez F, Barbes C; Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect. Immun. 66(5), 1985-1989 (1998). (Pubitemid 28194093)
45. Mastromarino P, Brigidi P, Macchia S et al.: Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J. Appl. Microbiol. 93(5), 884-893 (2002). (Pubitemid 35340893)
46. Vallor AC, Antonio MA, Hawes SE, Hillier SL: Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: Role of hydrogen peroxide production. J. Infect. Dis. 184(11), 1431-1436 (2001). (Pubitemid 33108857)
47. Antonio MA, Rabe LK, Hillier SL: Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J. Infect. Dis. 192(3), 394-398 (2005). (Pubitemid 41023117)
48. Kaufmann SH: Elie Metchnikoff 's and Paul Ehrlich's impact on infection biology. Microbes Infect. 10(14-15), 1417-1419 (2008).
49. Bruce AW, Chadwick P, Hassan A, VanCott GF: Recurrent urethritis in women. Can. Med. Assoc. J. 108(8), 973-976 (1973).
50. Bruce AW, Reid G: Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can. J. Microbiol. 34(3), 339-343 (1988).
51. Huffnagle GB, Wernick S: The Probiotics Revolution. Bantam Dell, NY, USA (2007).
52. Redondo-Lopez V, Cook RL, Sobel JD: Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev. Infect. Dis. 12(5), 856-872 (1990). (Pubitemid 20349968)
53. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA: Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect. Immun. 67(10), 5170-5175 (1999). (Pubitemid 29455288)
54. Wilson M: The reproductive system and its indiginous microbiota. In: Microbial Inhabitants of Humans: Their Ecology and Role in Health and Disease. Cambridge University Press, NY, USA, 206-250 (2005).
55. Juarez Tomas MS, Ocana VS, Wiese B, Nader-Macias ME: Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J. Med. Microbiol. 52(12), 1117-1124 (2003). (Pubitemid 38648157)
56. Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J. Physiol. Pharmacol. 60(S6), 13-18 (2009).
57. 2-generating Lactobacillus species for probiotic use. Curr. Microbiol. 38(5), 279-284 (1999). (Pubitemid 29203164)
58. McLean NW, Rosenstein IJ: Characterization and selection of a Lactobacillus species to re-colonize the vagina of women with recurrent bacterial vaginosis. J. Med. Microbiol. 49(6), 543-552 (2000). (Pubitemid 30347592)
59. Smith H, Yates EA, Cole JA, Parsons NJ: Lactate stimulation of gonococcal metabolism in media containing glucose: Mechanism, impact on pathogenicity, and wider implications for other pathogens. Infect. Immun. 69(11), 6565-6572 (2001). (Pubitemid 32995409)
60. Strus M, Kucharska A, Kukla G, Brzychczy- Wloch M, Maresz K, Heczko PB: The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect. Dis. Obstet. Gynecol. 13(2), 69-75 (2005). (Pubitemid 40979012)
61. Zarate G, Nader-Macias ME: Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett. Appl. Microbiol. 43(2), 174-180 (2006). (Pubitemid 44050632)
62. Rabe LK, Hillier SL: Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J. Clin. Microbiol. 41(7), 3260-3264 (2003). (Pubitemid 36842331)
63. Kim YH, Kim CH, Cho MK, Na JH, Song TB, Oh JS: Hydrogen peroxide-producing Lactobacilli in the vaginal flora of pregnant women with preterm labor with intact membranes. Int. J. Gynaecol. Obstet. 93(1), 22-27 (2006).
64. 2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J. Clin. Microbiol. 42(2), 713-717 (2004). (Pubitemid 38222651)
65. Schwebke JR: Role of vaginal flora as a barrier to HIV acquisition. Curr. Infect. Dis. Rep. 3(2), 152-155 (2001).
66. Knezevic A, Stepanovic S, Cupic M, Jevtovic D, Ranin J, Jovanovic T: Reduced quantity and hydrogen-peroxide production of vaginal lactobacilli in HIV positive women. Biomed. Pharmacother. 59(9), 521-523 (2005). (Pubitemid 41642952)
67. Atassi F, Brassart D, Grob P, Graf F, Servin AL: Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunol. Med. Microbiol. 48(3), 424-432 (2006). • Human vaginal isolates of L. jensenii and L. gasseri have antibiotic-like activity against the bacterial vaginosis-associated pathogens Prevotella bivia and Gardnerella vaginalis, and therefore, may be excellent candidates for probiotic use in the vaginal tract. (Pubitemid 44736582)
68. Ocaña VS, Pesce De Ruiz Holgado AA, Nader-Macías ME: Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl. Environ. Microbiol. 65(12), 5631-5635 (1999). (Pubitemid 129520666)
69. Saigh JH, Sanders CC, Sanders WEJ: Inhibition of Neisseria gonorrhoeae by aerobic and facultatively anaerobic components of the endocervical flora: Evidence for a protective effect against infection. Infect. Immun. 19(2), 704-710 (1978). (Pubitemid 8289609)
70. St. Amant DC, Valentin-Bon IE, Jerse AE: Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract. Infect. Immun. 70(12), 7169-7171 (2002). (Pubitemid 35387959)
71. 2-producing lactobacilli on Neisseria gonorrhoeae growth and catalase activity. J. Infect. Dis. 170(5), 1209-1215 (1994). (Pubitemid 24328625)
72. Atassi F, Servin AL: Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens. FEMS Microbiol. Lett. 304(1), 29-38 (2010).
73. 2 by vaginal lactobacilli. Appl. Env. Microbiol. 76(2), 400-405 (2010).
74. Genco CA, Desai PJ: Iron acquisition in the pathogenic Neisseria. Trends Microbiol. 4(5), 179-184 (1996). (Pubitemid 26162131)
75. Kawai Y, Kemperman R, Kok J, Saito T: The circular bacteriocins gassericin A and circularin A. Curr. Prot. Pept. Sci. 5(5), 393-398 (2004). (Pubitemid 39200169)
76. Majhenic AC, Venema K, Allison GE, Matijasi BB, Rogelj I, Klaenhammer TR: DNA analysis of the genes encoding acidocin LF221 A and acidocin LF221 B, two bacteriocins produced by Lactobacillus gasseri LF221. Appl. Microbiol. Biotechnol. 63(6), 705-714 (2004). (Pubitemid 38316699)
77. Tahara T, Yoshioka S, Utsumi R, Kanatani K. Isolation and partial characterization of bacteriocins produced by Lactobacillus gasseri JCM 2124. FEMS Microbiol. Lett. 148(1), 97-100 (1997). (Pubitemid 27128363)
78. Pascual LM, Daniele MB, Giordano W, Pajaro MC, Barberis IL: Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23. Curr. Microbiol. 56(4), 397-402 (2008).
79. Kaewsrichan J, Peeyananjarassri K, Kongprasertkit J: Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immun. Med. Microbiol. 48(1), 75-83 (2006). (Pubitemid 44379222)
80. Kawai Y, Kusnadi J, Kemperman R et al.: DNA sequencing and homologous expression of a small peptide conferring immunity to gassericin A, a circular bacteriocin produced by Lactobacillus gasseri LA39. Appl. Environ. Microbiol. 75(5), 1324-1330 (2009).
81. McGroarty JA, Reid G: Detection of a Lactobacillus substance that inhibits Escherichia coli. Can. J. Microbiol. 34(8), 974-978 (1988). (Pubitemid 18269302)
82. Turovskiy Y, Ludescher RD, Aroutcheva AA, Faro S, Chikindas ML: Lactocin 160, a bacteriocin produced by vaginal Lactobacillus rhamnosus, targets cytoplasmic membranes of the vaginal pathogen, Gardnerella vaginalis. Probiotics Antimicrob. Proteins 1(1), 67-74 (2009). • The bacteriocin Lactocin 160, produced by a vaginal isolate of Lactobacillus rhamnosus, inhibits G. vaginalis by producing holes in the cytoplasmic membrane of the pathogen.
83. Martin R, Soberon N, Vaneechoutte M, Florez AB, Vazquez F, Suarez JE: Characterization of indigenous vaginal lactobacilli from healthy women as probiotic candidates. Int. Microbiol. 11(4), 261-266 (2008).
84. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl Acad. Sci. USA 104(18), 7617-7621 (2007). (Pubitemid 47185955)
85. Reid G, McGroarty JA, Angotti R, Cook RL: Lactobacillus inhibitor production against Escherichia coli and coaggregation ability with uropathogens. Can. J. Microbiol. 34(3), 344-351 (1988).
86. Ekmekci H, Aslim B, Ozturk S: Characterization of vaginal lactobacilli coaggregation ability with Escherichia coli. Microbiol. Immunol. 53(2), 59-65 (2009).
87. Kmet V, Lucchini F: Aggregation-promoting factor in human vaginal Lactobacillus strains. FEMS Immun. Med. Microbiol. 19(2), 111-114 (1997). (Pubitemid 27467063)
88. Atassi F, Brassart D, Grob P, Graf F, Servin AL: In vitro antibacterial activity of Lactobacillus helveticus strain KS300 against diarrhoeagenic, uropathogenic and vaginosis-associated bacteria. J. Appl. Microbiol. 101(3), 647-654 (2006). (Pubitemid 44222295)
89. Atassi F, Brassart D, Grob P, Graf F, Servin AL: Vaginal Lactobacillus isolates inhibit uropathogenic Escherichia coli. FEMS Microbiol. Lett. 257(1), 132-138 (2006).
90. Osset J, Bartolome RM, Garcia E, Andreu A: Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J. Infect. Dis. 183(3), 485-491 (2001). (Pubitemid 32105607)
91. Saunders S, Bocking A, Challis J, Reid G: Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf. B. Biointerfaces. 55(2), 138-142 (2007).
92. Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW: Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect. Immun. 47(1), 84-89 (1985). (Pubitemid 15194595)
93. Zarate G, Santos V, Nader-Macias ME: Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model. Infect. Dis. Obstet. Gynecol. 48358 (2009).
94. Greene JD, Klaenhammer TR: Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol. 60(12), 4487-4494 (1994). (Pubitemid 24370819)
95. Henriksson A, Szewzyk R, Conway PL: Characteristics of the adhesive determinants of Lactobacillus fermentum 104. Appl. Environ. Microbiol. 57(2), 499-502 (1991).
96. Kankainen M, Paulin L, Tynkkynen S et al.: Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc. Natl Acad. Sci. USA 106(40), 17193-17198 (2009).
97. Miyoshi Y, Okada S, Uchimura T, Satoh E: A mucus adhesion promoting protein, MapA, mediates the adhesion of Lactobacillus reuteri to Caco-2 human intestinal epithelial cells. Biosci. Biotechnol. Biochem. 70(7), 1622-1628 (2006). (Pubitemid 44124920)
98. Reid G, Servin AL, Bruce AW, Busscher HJ: Adhesion of three Lactobacillus strains to human urinary and intestinal epithelial cells. Microbios. 75(302), 57-65 (1993).
99. Adlerberth I, Ahrne S, Johansson ML, Molin G, Hanson LA, Wold AE: A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl. Environ. Microbiol. 62(7), 2244-2251 (1996). (Pubitemid 26231184)
100. Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE, Molin G: The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 85(1), 88-94 (1998). (Pubitemid 28363983)
101. Coconnier MH, Klaenhammer TR, Kerneis S, Bernet MF, Servin AL: Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture. Appl. Environ. Microbiol. 58(6), 2034-2039 (1992).
102. Granato D, Perotti F, Masserey I et al.: Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl. Environ. Microbiol. 65(3), 1071-1077 (1999).
103. Neeser JR, Granato D, Rouvet M, Servin A, Teneberg S, Karlsson KA: Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology 10(11), 1193-1199 (2000).
104. Aleljung P, Shen W, Rozalska B, Hellman U, Ljungh A, Wadstrom T: Purification of collagen-binding proteins of Lactobacillus reuteri NCIB 11951. Curr. Microbiol. 28(4), 231-236 (1994). (Pubitemid 24112882)
105. Antikainen J, Anton L, Sillanpaa J, Korhonen TK: Domains in the S-layer protein CbsA of Lactobacillus crispatus involved in adherence to collagens, laminin and lipoteichoic acids and in self-assembly. Mol. Microbiol. 46(2), 381-394 (2002). (Pubitemid 35340951)
106. Antikainen J, Kuparinen V, Lähteenmäki K, Korhonen TK: Enolases from Gram-positive bacterial pathogens and commensal lactobacilli share functional similarity in virulence-associated traits. FEMS Immun. Med. Microbiol. 51(3), 526-534 (2007). (Pubitemid 350076163)
107. Castaldo C, Vastano V, Siciliano RA et al.: Surface displaced alfa-enolase of Lactobacillus plantarum is a fibronectin binding protein. Microb. Cell Fact. 8, 14 (2009).
108. Hynonen U, Westerlund-Wikstrom B, Palva A, Korhonen TK: Identification by flagellum display of an epithelial cell- and fibronectin-binding function in the SlpA surface protein of Lactobacillus brevis. J. Bacteriol. 184(12), 3360-3367 (2002). (Pubitemid 34568946)
109. Kapczynski DR, Meinersmann RJ, Lee MD: Adherence of Lactobacillus to intestinal 407 cells in culture correlates with fibronectin binding. Curr. Microbiol. 41(2), 136-141 (2000). (Pubitemid 30437607)
110. Lindgren SE, Swaisgood HE, Janolino VG et al.: Binding of Lactobacillus reuteri to fibronectin immobilized on glass beads. Zentralbl. Bakteriol. 277(4), 519-528 (1992).
111. Roos S, Aleljung P, Robert N et al.: A collagen binding protein from Lactobacillus reuteri is part of an ABC transporter system? FEMS Microbiol. Lett. 144(1), 33-38 (1996). (Pubitemid 26343107)
112. Sillanpaa J, Martinez B, Antikainen J et al.: Characterization of the collagen-binding S-layer protein CbsA of Lactobacillus crispatus. J. Bacteriol. 182(22), 6440-6450 (2000).
113. Heinemann C, van Hylckama Vlieg JE, Janssen DB, Busscher HJ, van der Mei HC, Reid G: Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131. FEMS Microbiol. Lett. 190(1), 177-180 (2000). (Pubitemid 30645855)
114. Alander M, Satokari R, Korpela R et al.: Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Env. Microbiol. 65(1), 351-354 (1999). (Pubitemid 29029667)
115. Antikainen J, Kuparinen V, Lähteenmäki K, Korhonen TK: PH-dependent association of enolase and glyceraldehyde-3-phosphate dehydrogenase of Lactobacillus crispatus with the cell wall and lipoteichoic acids. Erratum in: J. Bacteriol. 189(15), 5788 (2007). (Pubitemid 47206427)
116. J. Bacteriol. 189(12), 4539-4543 (2007).
117. Sánchez B, Schmitter JM, Urdaci MC: Identification of novel proteins secreted by Lactobacillus plantarum that bind to mucin and fibronectin. J. Mol. Microbiol. Biotechnol. 17(3), 158-162 (2009).
118. Spurbeck RR, Arvidson CG: Lactobacillus jensenii surface associated proteins Inhibit Neisseria gonorrhoeae adherence to epithelial cells. Infect. Immun. 78(7), 3103-3111 (2010).
119. Johnson-Henry KC, Hagen KE, Gordonpour M, Tompkins TA, Sherman PM: Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell. Microbiol. 9(2), 356-367 (2007). (Pubitemid 46092165)
120. Toba T, Virkola R, Westerlund B et al.: A collagen-binding S-layer protein in Lactobacillus crispatus. Appl. Environ. Microbiol. 61(7), 2467-2471 (1995).
121. Ventura M, Jankovic I, Walker DC, Pridmore RD, Zink R: Identification and characterization of novel surface proteins in Lactobacillus johnsonii and Lactobacillus gasseri. Appl. Environ. Microbiol. 68(12), 6172-6181 (2002). (Pubitemid 36342454)
122. Boot HJ, Kolen CP, Pot B, Kersters K, Pouwels PH: The presence of two S-layer-protein-encoding genes is conserved among species related to Lactobacillus acidophilus. Microbiology 142(9), 2375-2384 (1996). (Pubitemid 26333768)
123. Pavlova SI, Kilic AO, Kilic SS et al.: Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J. Appl. Microbiol. 92(3), 451-459 (2002). (Pubitemid 34227136)
124. Rodrigues LR, Banat IM, Teixeira JA, Oliveira R: Biosurfactants: Potential applications in medicine. J. Antimicrob. Chemother. 57(4), 609-618 (2006).
125. Singh P, Cameotra SS: Potential applications of microbial surfactants in biomedical sciences. Trends Biotechnol. 22(3), 142-146 (2004). (Pubitemid 38230393)
126. Ron EZ, Rosenberg E: Natural roles of biosurfactants. Environ. Microbiol. 3(4), 229-236 (2001). (Pubitemid 33141493)
127. Reid G, Heinemann C, Velraeds M, van der Mei HC, Busscher HJ: Biosurfactants produced by Lactobacillus. Meth. Enzymol. 310, 426-433 (1999). (Pubitemid 29504295)
128. Velraeds MM, van der Mei HC, Reid G, Busscher HJ: Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl. Environ. Microbiol. 62(6), 1958-1963 (1996). (Pubitemid 26168987)
129. Velraeds MM, van der Mei HC, Reid G, Busscher HJ: Inhibition of initial adhesion of uropathogenic Enterococcus faecalis to solid substrata by an adsorbed biosurfactant layer from Lactobacillus acidophilus. Urology 49(5), 790-794 (1997). (Pubitemid 27194604)
130. Velraeds MM, van de Belt-Gritter B, Busscher HJ, Reid G, van der Mei HC: Inhibition of uropathogenic biofilm growth on silicone rubber in human urine by lactobacilli - a teleologic approach. World J. Urol. 18(6), 422-426 (2000).
131. Gan BS, Kim J, Reid G, Cadieux P, Howard JC: Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis. 185(9), 1369-1372 (2002). (Pubitemid 34439150)
132. Walencka E, Rózalska S, Sadowska B, Rózalska B: The influence of Lactobacillus acidophilus-derived surfactants on staphylococcal adhesion and biofilm formation. Folia Microbiol. 53(1), 61-66 (2008). (Pubitemid 351690787)
133. Rose MC: Mucins: Structure, function, and role in pulmonary diseases. Am. J. Physiol. 263(4), L413-L429 (1992).
134. Amit-Romach E, Uni Z, Reifen R: Multistep mechanism of probiotic bacterium, the effect on innate immune system. Mol. Nutr. Food Res. 54(2), 277-284 (2009).
135. Kim Y, Kim S-H, Whang K-Y, Kim Y-J, Oh S: Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J. Microbiol. Biotechnol. 18(7), 1278-1285 (2008).
136. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276(4), G941-G950 (1999). • Lactobacilli induce mucin production from intestinal epithelial cells, which reduces the adherence of enteropathogenic Escherichia coli. (Pubitemid 29214108)
137. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52(6), 827-833 (2003). (Pubitemid 36613489)
138. Mattar AF, Teitelbaum DH, Drongowski RA, Yongyi F, Harmon CM, Coran AG: Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr. Surg. Int. 18(7), 586-590 (2002). (Pubitemid 36069911)
139. Domino SE, Hurd EA, Thomsson KA et al.: Cervical mucins carry a(1,2)fucosylated glycans that partly protect from experimental vaginal candidiasis. Glycoconj. J. 26(9), 1125-1134 (2009).
140. McGee ZA, Johnson AP, Taylor-Robinson D: Pathogenic mechanisms of Neisseria gonorrhoeae: Observations on damage to human Fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J. Infect. Dis. 143(3), 413-422 (1981). (Pubitemid 11113662)
141. Merz AJ, So M. Interactions of pathogenic Neisseriae with epithelial cell membranes. Annu. Rev. Cell Dev. Biol. 16, 423-457 (2000). (Pubitemid 32037513)
142. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM: Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7- induced changes in epithelial barrier function. Infect. Immun. 76(4), 1340-1348 (2008). (Pubitemid 351561979)
143. Qin H, Zhang Z, Hang X, Jiang Y: L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 9, 63 (2009).
144. Moorthy G, Murali MR, Devaraj SN: Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats. Nutrition 25(3), 350-358 (2009).
145. Putaala H, Salusjarvi T, Nordstrom M et al.: Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res. Microbiol. 159(9-10), 692-698 (2008).
146. Du Y, Lenz J, Arvidson CG: Global gene expression and the role of sigma factors in Neisseria gonorrhoeae in interactions with epithelial cells. Infect. Immun. 73(8), 4834-4845 (2005). (Pubitemid 41105640)
147. Kohler T, Buckling A, van Delden C: Cooperation and virulence of clinical Pseudomonas aeruginosa populations. Proc. Natl Acad. Sci. USA. 106(15), 6339-6344 (2009).
148. Medellin-Pena MJ, Wang H, Johnson R, Anand S, Griffiths MW: Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl. Environ. Microbiol. 73(13), 4259-4267 (2007). • An intestinal probiotic strain of Lactobacillus acidophilus inhibits the gene expression of the LEE locus in enterohemorrhagic E. coli, thus reducing the adherence of the pathogen to epithelial cells. (Pubitemid 47068166)
149. Bronner S, Monteil H, Prevost G: Regulation of virulence determinants in Staphylococcus aureus: Complexity and applications. FEMS Microbiol. Rev. 28(2), 183-200 (2004). (Pubitemid 38510501)
150. Laughton JM, Devillard E, Heinrichs DE, Reid G, McCormick JK: Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology 152(4), 1155-1167 (2006).
151. Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI: Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice. J. Microbiol. Immunol. Infect. 38(6), 383-393 (2005). (Pubitemid 43287248)
152. Nader de Macías ME, de Ruiz CS, López de Bocanera ME, Pesce de Ruiz Holgado AA: Preventive and therapeutic effects of lactobacilli on urinary tract infections in mice: Clinical microbiology. Anaerobe 2(2), 85-93 (1996).
153. Pascual L, Ruiz F, Giordano W, Barberis IL: Vaginal colonization and activity of the probiotic bacterium Lactobacillus fermentum L23 in a murine model of vaginal tract infection. J. Med. Microbiol. 59(3), 360-364 (2010).
154. Silva de Ruiz C, López de Bocanera ME, Nader de Macías ME, Pesce de Ruiz Holgado AA: Effect of lactobacilli and antibiotics on E. coli urinary infections in mice. Biol. Pharm. Bull. 19(1), 88-93 (1996). (Pubitemid 26057395)
155. Silva de Ruiz C, Rey M, Pesce de Ruiz Holgado AA, Nader de Macías ME: Experimental administration of estradiol on the colonization of Lactobacillus fermentum and Escherichia coli in the urogenital tract of mice. Biol. Pharm. Bull. 24(2), 127-134 (2001). (Pubitemid 32175561)
156. Taylor-Robinson D, Furr PM: Further observations on the murine model of Mycoplasma hominis infection. J. Med. Microbiol. 59(8), 970-975 (2010).
157. Hamad M, Muta'eb E, Abu-Shaqra Q, Fraij A, Abu-Elteen K, Yasin SR: Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection. Mycoses 49(2), 104-108 (2006).
158. Jerse AE: Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67(11), 5699-5708 (1999). (Pubitemid 29508088)
159. Jerse AE, Crow ET, Bordner AN et al.: Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal Lactobacilli. Infect. Immun. 70(5), 2549-2558 (2002). (Pubitemid 34413586)
160. Muench DF, Kuch DJ, Wu H et al.: Hydrogen peroxide-producing lactobacilli Inhibit gonococci in vitro but not during experimental genital tract infection. J. Inf. Dis. 199(9), 1369-1378 (2009).
161. Hedrich HJ, Bullock G: The Laboratory Mouse. Elsevier, MO, USA (2004).
162. Patton DL, Cosgrove-Sweeney YT, Rabe LK, Hillier SL: The pig-tailed macaque rectal model: Microflora and chlamydial infection. Sex. Transm. Dis. 28(7), 363-366 (2001). (Pubitemid 32613677)
163. Patton DL, Sweeney YC, Bohannon NJ et al.: Effects of doxycycline and anti-inflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques. J. Infect. Dis. 175, 648-654 (1997). (Pubitemid 27086169)
164. Patton DL, Sweeney YC, Rabe LK, Hillier SL: The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem. Erratum in: Sex. Transm. Dis. 24(3), 180 (1997). Sex. Transm. Dis. 23(6), 489-493 (1996). (Pubitemid 26391573)
165. Patton DL, Sweeney YTC, Clark AM, Stamm WE: Antibiotic/antiinflammatory treatment of acute chlamydial upper genital tract infection in female macaques. Presented at: Third Meeting of the European Society for Chlamydial Research. Vienna, Austria, 11-14 September 1996.
166. Patton DL, Kuo C, Wang SP, Halbert SA: Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J. Infect. Dis. 155(5), 1292-1299 (1987). (Pubitemid 17080508)
167. Patton DL, Cosgrove Sweeney YT, Antonio MA, Rabe LK, Hillier SL: Lactobacillus crispatus capsules: Single-use safety study in the Macaca nemestrina model. Sex. Transm. Dis. 30(7), 568-570 (2003). (Pubitemid 36828981)
168. Chandler FWJ, Kraus SJ: Animal model of human disease. Gonorrhea. Am. J. Path. 82(2), 437-440 (1976).
169. Herthelius M, Gorbach SL, Möllby R, Nord CE, Pettersson L, Winberg J: Elimination of vaginal colonization with Escherichia coli by administration of indigenous flora. Infect. Immun. 57(8), 2447-2451 (1989). (Pubitemid 19183856)
170. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G: The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG 112(2), 234-240 (2005). (Pubitemid 40188254)
171. Anukam K, Osazuwa E, Ahonkhai I et al.: Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial. Microbes Infect. 8(6), 1450-1454 (2006). (Pubitemid 43903313)
172. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G: Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 8(12-13), 2772-2776 (2006). (Pubitemid 44692555)
173. Reid G, Charbonneau D, Erb J et al.: Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35(2), 131-134 (2003). (Pubitemid 36298934)